2014 Form 10-K Financial Statement

#000114420415017897 Filed on March 24, 2015

View on sec.gov

Income Statement

Concept 2014 2013 Q4 2013
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.700M $1.410M $4.440M
YoY Change -16.67% 50.0% 22.31%
% of Gross Profit
Research & Development $5.964M $1.550M $6.860M
YoY Change -13.06% 26.02% 33.92%
% of Gross Profit
Depreciation & Amortization $367.2K $90.00K $424.8K
YoY Change -13.55% -25.0% -14.58%
% of Gross Profit
Operating Expenses $5.964M $2.960M $6.860M
YoY Change -13.06% 37.04% 33.92%
Operating Profit -$9.891M -$12.40M
YoY Change -20.25% 41.66%
Interest Expense -$446.3K $110.0K -$9.348K
YoY Change 4674.43% 1000.0% 12.15%
% of Operating Profit
Other Income/Expense, Net $1.839M $0.00 $1.620M
YoY Change 13.53% -3939.0%
Pretax Income -$8.050M -$3.950M -$10.78M
YoY Change -25.32% 82.87% 22.5%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$8.052M -$3.950M -$10.78M
YoY Change -25.32% 82.87% 22.57%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$161.0M -$131.7M -$359.3M
COMMON SHARES
Basic Shares Outstanding 57.40M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 2013 Q4 2013
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.420M $2.420M $2.420M
YoY Change 289.26% -48.29% -48.29%
Cash & Equivalents $9.420M $2.418M $2.420M
Short-Term Investments
Other Short-Term Assets $280.0K $350.0K $350.0K
YoY Change -20.0% -23.91% -23.91%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $9.700M $2.768M $2.770M
YoY Change 250.18% -46.05% -46.0%
LONG-TERM ASSETS
Property, Plant & Equipment $2.030M $2.361M $2.360M
YoY Change -13.98% -10.75% -10.94%
Goodwill $1.675M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.00K $11.87K $10.00K
YoY Change 0.0% -56.39% -99.51%
Total Long-Term Assets $3.720M $4.048M $4.050M
YoY Change -8.15% -36.23% -36.22%
TOTAL ASSETS
Total Short-Term Assets $9.700M $2.768M $2.770M
Total Long-Term Assets $3.720M $4.048M $4.050M
Total Assets $13.42M $6.816M $6.820M
YoY Change 96.77% -40.62% -40.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $930.0K $1.160M $1.160M
YoY Change -19.83% 61.11% 61.11%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $120.0K $0.00 $0.00
YoY Change
Total Short-Term Liabilities $6.230M $4.523M $4.520M
YoY Change 37.83% 517.33% 519.18%
LONG-TERM LIABILITIES
Long-Term Debt $340.0K $450.0K $450.0K
YoY Change -24.44% 0.0% 0.0%
Other Long-Term Liabilities $150.0K $140.0K $140.0K
YoY Change 7.14% 0.0% 0.0%
Total Long-Term Liabilities $490.0K $593.2K $590.0K
YoY Change -16.95% 1.05% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.230M $4.523M $4.520M
Total Long-Term Liabilities $490.0K $593.2K $590.0K
Total Liabilities $6.720M $5.116M $5.120M
YoY Change 31.25% 287.67% 287.88%
SHAREHOLDERS EQUITY
Retained Earnings -$51.06M
YoY Change
Common Stock $29.00
YoY Change -93.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.700M $1.700M $1.700M
YoY Change
Total Liabilities & Shareholders Equity $13.42M $6.816M $6.820M
YoY Change 96.77% -40.62% -40.59%

Cashflow Statement

Concept 2014 2013 Q4 2013
OPERATING ACTIVITIES
Net Income -$8.052M -$3.950M -$10.78M
YoY Change -25.32% 82.87% 22.57%
Depreciation, Depletion And Amortization $367.2K $90.00K $424.8K
YoY Change -13.55% -25.0% -14.58%
Cash From Operating Activities -$8.840M -$2.670M -$9.150M
YoY Change -3.39% 57.06% 38.85%
INVESTING ACTIVITIES
Capital Expenditures $29.57K -$20.00K $147.8K
YoY Change -80.0% -66.67% 51.31%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $2.000M
YoY Change -100.0% -100.0% -200.0%
Cash From Investing Activities -$30.00K -$20.00K $1.850M
YoY Change -101.62% -99.03% -188.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $12.40M -$4.975M
YoY Change -349.16% -27.25%
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities 15.87M 0.000 5.040M
YoY Change 214.88% -100.0% -35.8%
NET CHANGE
Cash From Operating Activities -8.840M -2.670M -9.150M
Cash From Investing Activities -30.00K -20.00K 1.850M
Cash From Financing Activities 15.87M 0.000 5.040M
Net Change In Cash 7.000M -2.690M -2.260M
YoY Change -409.73% 189.25% 169.05%
FREE CASH FLOW
Cash From Operating Activities -$8.840M -$2.670M -$9.150M
Capital Expenditures $29.57K -$20.00K $147.8K
Free Cash Flow -$8.870M -$2.650M -$9.298M
YoY Change -4.61% 61.59% 39.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2184590 USD
CY2014Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1128499 USD
CY2014Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2180 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4523155 USD
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
933988 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1162098 USD
CY2013Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3359363 USD
CY2013Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
1694 USD
CY2013Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
0 USD
CY2013Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
143234 USD
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
488977 USD
CY2014Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
147774 USD
CY2014Q4 us-gaap Liabilities
Liabilities
2673567 USD
CY2013Q4 us-gaap Liabilities
Liabilities
5116389 USD
CY2014Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
11126 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
69911836 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
1699550 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
76 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
52759089 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51059568 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6815939 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59165963 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
10745949 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13419516 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
294687 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9422627 USD
CY2014Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
55000 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
220611 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
9698238 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2033944 USD
CY2014Q4 us-gaap Goodwill
Goodwill
1675462 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11872 USD
CY2014Q4 us-gaap Assets
Assets
13419516 USD
CY2014Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
330077 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
29 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2418384 USD
CY2013Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
55000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
2768071 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2360534 USD
CY2013Q4 us-gaap Goodwill
Goodwill
1675462 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11872 USD
CY2013Q4 us-gaap Assets
Assets
6815939 USD
CY2013Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2014Q4 us-gaap Notes Payable Current
NotesPayableCurrent
119923 USD
CY2013Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
450000 USD
CY2013Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
593234 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
333907 shares
CY2014Q4 clrb Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Unvested Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsUnvestedOutstandingNumber
385559 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
333907 shares
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4444767 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3704676 USD
CY2014 us-gaap Costs And Expenses
CostsAndExpenses
9890945 USD
CY2014 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
1 pure
CY2013 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P3Y10M20D
CY2014 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P3Y1M20D
CY2014Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
275000 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
6604096 shares
CY2014 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0107 pure
CY2013 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
1.15 pure
CY2013 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0263 pure
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2869739 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7562762 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2869739 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7562762 shares
CY2014Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
13475832 USD
CY2014Q3 us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
11877143 USD
CY2014Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1598689 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
2323233 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
850350 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.09 pure
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.20
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.69
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.60
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.01
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
321959 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
634658 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
344278 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
120300 shares
CY2013 clrb Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
9452 shares
CY2014 clrb Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
18437 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
22127 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
17055 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
719466 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.40
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
18.07
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.20
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.69
CY2013 clrb Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice
117.80
CY2014 clrb Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice
24.19
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
15.60
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
14.58
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.59
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
24.53
CY2014Q4 clrb Share Based Compensation Arrangement By Share Based Payment Award Options Non Vested Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedExercisableWeightedAverageExercisePrice
7.85
CY2014Q4 clrb Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingAggregateIntrinsicValue
17500 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 USD
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
81805 shares
CY2014 clrb Employee Service Share Based Compensation Nonvested Total Compensation In Current Year
EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInCurrentYear
615754 USD
CY2014 clrb Employee Service Share Based Compensation Nonvested Total Compensation In Year Two
EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInYearTwo
455975 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
24.53
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y7M10D
CY2014 clrb Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingWeightedAverageRemainingContractualTerm
P9Y1M2D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M10D
CY2014 clrb Employee Service Share Based Compensation Nonvested Total Compensation In Year Three
EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInYearThree
265240 USD
CY2014Q4 clrb Share Based Compensation Arrangement By Sharebased Payment Award Options Unvested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedAndExpectedToVestOutstandingNumber
253754 shares
CY2014 clrb Estimated Stock Based Compensation Expense Up On Vesting Of Options
EstimatedStockBasedCompensationExpenseUpOnVestingOfOptions
418024 USD
CY2014Q1 clrb Antidilution Option Reduced By Expiration Of Warrants
AntidilutionOptionReducedByExpirationOfWarrants
14474 shares
CY2014Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.00
CY2013Q4 clrb Antidilution Option Reduced Rate
AntidilutionOptionReducedRate
19 shares
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1754993 USD
CY2014 us-gaap Severance Costs1
SeveranceCosts1
160000 USD
CY2013 clrb Payment Towards Clinical Trial Agreements
PaymentTowardsClinicalTrialAgreements
380625 USD
CY2014 clrb Payment Towards Clinical Trial Agreements
PaymentTowardsClinicalTrialAgreements
508000 USD
CY2013 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
187500 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6860163 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5964453 USD
CY2013 us-gaap Restructuring Costs
RestructuringCosts
1096874 USD
CY2014 us-gaap Restructuring Costs
RestructuringCosts
221816 USD
CY2013 us-gaap Costs And Expenses
CostsAndExpenses
12401804 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-12401804 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-9890945 USD
CY2013 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
2373941 USD
CY2014 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
2230864 USD
CY2013 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-744957 USD
CY2014 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
CY2013 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-9348 USD
CY2014 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-446314 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1619636 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1784550 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-10782168 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-8106395 USD
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.86
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.77
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2794557 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4592657 shares
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
424758 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
367197 USD
CY2013 us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
CY2014 us-gaap Other Noncash Expense
OtherNoncashExpense
426458 USD
CY2013 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-7523 USD
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2269 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
445108 USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-228110 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-48056 USD
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-74076 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9154644 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8840479 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
147812 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29569 USD
CY2013 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-2000000 USD
CY2014 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1852188 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-29569 USD
CY2013 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2014 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
4000000 USD
CY2013 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2014 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
617500 USD
CY2013 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2014 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
617500 USD
CY2013 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
2397 USD
CY2014 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
1694 USD
CY2013 clrb Reverse Stock Split Fractional Shares
ReverseStockSplitFractionalShares
0 USD
CY2014 clrb Reverse Stock Split Fractional Shares
ReverseStockSplitFractionalShares
1158 USD
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4975153 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12395965 USD
CY2013 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2014 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
518822 USD
CY2013 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
70539 USD
CY2014 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5043295 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
15874291 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2259161 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7004243 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4677545 USD
CY2013 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2014 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
4172435 USD
CY2013 clrb Fair Value Of Warrants Classified As Derivative Liability
FairValueOfWarrantsClassifiedAsDerivativeLiability
5720000 USD
CY2014 clrb Fair Value Of Warrants Classified As Derivative Liability
FairValueOfWarrantsClassifiedAsDerivativeLiability
0 USD
CY2013 clrb Debt Conversion Converted Instrument Value Warrants Issued
DebtConversionConvertedInstrumentValueWarrantsIssued
0 USD
CY2014 clrb Debt Conversion Converted Instrument Value Warrants Issued
DebtConversionConvertedInstrumentValueWarrantsIssued
254024 USD
CY2013 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
7830 USD
CY2014 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
4540 USD
CY2013 us-gaap Interest Paid
InterestPaid
0 USD
CY2014 us-gaap Interest Paid
InterestPaid
3156 USD
CY2013 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
13306 USD
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Entity Registrant Name
EntityRegistrantName
Cellectar Biosciences, Inc.
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001279704
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q2 dei Entity Public Float
EntityPublicFloat
12793777 USD
CY2014 dei Trading Symbol
TradingSymbol
CLRB
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7562762 shares
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5625482 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5646058 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3264948 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3612114 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
112657 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
136022 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
171835 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
569496 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
47853 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
101972 USD
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2109200 USD
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
936310 USD
CY2014Q4 clrb Deferred Tax Assets Tax Credit Carry Forwards Domestic Research And Development
DeferredTaxAssetsTaxCreditCarryForwardsDomesticResearchAndDevelopment
2689775 USD
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4705250 USD
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3868524 USD
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
134225 USD
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
810914 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
10158375 USD
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4975153 USD
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11877143 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2323233 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
850350 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4571025 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3057610 USD
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4571025 USD
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3057610 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
25731718 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
29246965 USD
CY2013Q4 clrb Deferred Tax Assets Tax Credit Carry Forwards Domestic Research And Development
DeferredTaxAssetsTaxCreditCarryForwardsDomesticResearchAndDevelopment
2480417 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
2070642 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1813954 USD
CY2013Q4 clrb Deferred Tax Assets Tax Credit Carry Forwards State And Local Research And Development
DeferredTaxAssetsTaxCreditCarryForwardsStateAndLocalResearchAndDevelopment
724200 USD
CY2014Q4 clrb Deferred Tax Assets Tax Credit Carry Forwards State And Local Research And Development
DeferredTaxAssetsTaxCreditCarryForwardsStateAndLocalResearchAndDevelopment
753818 USD
CY2013Q4 clrb Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs
DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
11128803 USD
CY2014Q4 clrb Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs
DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
10609942 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1599005 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1758909 USD
CY2013Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
380339 USD
CY2014Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
313412 USD
CY2013Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
34850 USD
CY2014Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
26112 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
35392 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
44176086 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
47222167 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
257314 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
245785 USD
CY2013Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
257314 USD
CY2014Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
245785 USD
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
43918772 USD
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
46976382 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
43918772 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
46976382 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2014Q1 clrb Convertible Debentures And Warrants To Purchase Common Stock
ConvertibleDebenturesAndWarrantsToPurchaseCommonStock
400000 shares
CY2013Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
55000 USD
CY2014Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
55000 USD
CY2014Q1 clrb Payment For Convertible Debentures
PaymentForConvertibleDebentures
4000000 USD
CY2014 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2014 clrb Lease Term
LeaseTerm
P3Y
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
826365 shares
CY2014Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
551365 shares
CY2014Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
9173000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
130000 USD
CY2014 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
17000 USD
CY2014Q1 us-gaap Convertible Debt
ConvertibleDebt
4000000 USD
CY2014 us-gaap Debt Instrument Interest Rate Stated Percentage Rate Range Minimum
DebtInstrumentInterestRateStatedPercentageRateRangeMinimum
0.12 pure
CY2010Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
450000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
88000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
0 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
218000 USD
CY2013 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
9000 USD
CY2010 clrb Interest And Principal Payments Period
InterestAndPrincipalPaymentsPeriod
2015-04-30
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></b> <font style="FONT-SIZE: 10pt">&#151; The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and judgments that may affect the reported amounts of assets, liabilities, revenue and expenses and disclosure of contingent assets and liabilities. On an on-going basis, management evaluates its estimates including those related to unbilled vendor amounts and share-based compensation. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from those estimates under different assumptions or conditions. Changes in estimates are reflected in reported results in the period in which they become known.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014 clrb Unpaid Principal And Interest Description
UnpaidPrincipalAndInterestDescription
Monthly payments of $20,665 for principal and interest commence on May 1, 2015 and continue for 23 equal installments with the final installment of any remaining unpaid principal and interest due on April 1, 2017.
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
119923 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
243590 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
86487 USD
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
450000 USD
CY2007 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
8050 USD
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
229000 USD
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
180000 USD
CY2014 clrb Lease Rent Expansion Space
LeaseRentExpansionSpace
1140 USD
CY2014Q4 clrb Expansion Space For Lease
ExpansionSpaceForLease
3400 sqft
CY2014 clrb Lease Rent Escalation Percentage
LeaseRentEscalationPercentage
0.03 pure
CY2014 clrb Maximum Renovation Expense
MaximumRenovationExpense
55000 USD
CY2013 clrb Number Of Shares Reserved For Future Issuance
NumberOfSharesReservedForFutureIssuance
2473781 shares
CY2014 clrb Number Of Shares Reserved For Future Issuance
NumberOfSharesReservedForFutureIssuance
7323562 shares
CY2003Q3 clrb Payment Of License Fee
PaymentOfLicenseFee
10000 USD
CY2003Q3 clrb Payment Of Sublicense Fee Description
PaymentOfSublicenseFeeDescription
if the sublicense fee payable to the Company is between 4% and 5% of net sales, then the royalties payable to U. Mich. Shall be equal to 50% of the sublicense fee.
CY2003Q3 clrb Percentage Of Revenue Received In Kind
PercentageOfRevenueReceivedInKind
0.1 pure
CY2014 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">Concentration of Credit Risk</font></i></b> <font style="FONT-SIZE: 10pt">&#151; Financial instruments that subject the Company to credit risk consist of cash and equivalents on deposit with financial institutions. The Company&#8217;s excess cash as of December 31, 2014 and 2013 is on deposit in a non-interest-bearing transaction account with a well-established financial institution. At times, such amounts may exceed the FDIC insurance limits. As of December 31, 2014, uninsured cash balances totaled approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9,173,000</font>.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014 clrb Resale Of Shares Of Common Stock
ResaleOfSharesOfCommonStock
200000 shares
CY2013Q4 clrb Warrants Issued To Purchase Common Stock
WarrantsIssuedToPurchaseCommonStock
275000 shares
CY2013Q4 clrb Fair Value Of Warrants Classified As Derivative Liability Outstanding
FairValueOfWarrantsClassifiedAsDerivativeLiabilityOutstanding
5720000 USD
CY2013 clrb Change In Unrealized Gain Loss On Fair Value
ChangeInUnrealizedGainLossOnFairValue
2365000 USD
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0082 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0660 pure
CY2013 clrb Effective Income Tax Rate Reconciliation Permanent Adjustment
EffectiveIncomeTaxRateReconciliationPermanentAdjustment
0.0510 pure
CY2014 clrb Effective Income Tax Rate Reconciliation Permanent Adjustment
EffectiveIncomeTaxRateReconciliationPermanentAdjustment
0.0933 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.4240 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.3772 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0412 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0099 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2013 clrb Adjustments To Additional Paid In Capital Warrants Issued Sale Of Common Stock
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedSaleOfCommonStock
4975043 USD
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
550000 shares
CY2014 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
2227500 USD
CY2014 clrb Stock And Warrants Issued Value To Extinguish Convertible Debentures
StockAndWarrantsIssuedValueToExtinguishConvertibleDebentures
4172435 USD
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2014 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
254024 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
1158 USD
CY2014Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
At the annual meeting of stockholders held on May 22, 2014, the Company&#8217;s stockholders approved an amendment to the certificate of incorporation to effect a reverse split of the Company&#8217;s common stock at a ratio between 1:10 to 1:20 in order to satisfy requirements for the listing of the Company&#8217;s common stock on the NASDAQ Capital Market. In addition, the proposal approved by the stockholders provided that if the reverse split was effected, the number of shares of common stock that the Company is authorized to issue would be reduced from 150,000,000 to the greater of (A) 20,000,000 and (B) the number of shares equal to three (3) times the sum of the number of all shares of common stock outstanding and the number of shares of common stock issuable upon exercise or conversion of all outstanding options, warrants and convertible debt.
CY2014Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-20 reverse split
CY2013 us-gaap Restructuring Charges
RestructuringCharges
1097000 USD
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
17.60
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
14.55
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.60
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
4.67

Files In Submission

Name View Source Status
0001144204-15-017897-index-headers.html Edgar Link pending
0001144204-15-017897-index.html Edgar Link pending
0001144204-15-017897.txt Edgar Link pending
0001144204-15-017897-xbrl.zip Edgar Link pending
clrb-20141231.xml Edgar Link completed
clrb-20141231.xsd Edgar Link pending
clrb-20141231_cal.xml Edgar Link unprocessable
clrb-20141231_def.xml Edgar Link unprocessable
clrb-20141231_lab.xml Edgar Link unprocessable
clrb-20141231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v403920_10k.htm Edgar Link pending
v403920_ex21-1.htm Edgar Link pending
v403920_ex23-1.htm Edgar Link pending
v403920_ex31-1.htm Edgar Link pending
v403920_ex31-2.htm Edgar Link pending
v403920_ex32-1.htm Edgar Link pending